Compare Enveric Biosciences Inc (ENVB) vs Moderna, Inc. (MRNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs Moderna, Inc. — how do they compare? Enveric Biosciences Inc trades at $1.38 (market cap $5.32M), while Moderna, Inc. trades at $64.16 (market cap $27.09B). The key difference: Moderna, Inc. is far larger — about 5092.1× Enveric Biosciences Inc's market cap, and Moderna, Inc. is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| ENVB | MRNA | |
|---|---|---|
Market Cap | $5.32M | $27.09B |
Sector | Health | Health |
52-Week High | $17.40 | $81.80 |
52-Week Low | $1.28 | $22.36 |
Enterprise Value | $408.82K | $23.19B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →
